Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of intestinal microbiota and serum metabolites in patients with mild hepatic encephalopathy

1 Jan 2022

Abstract excerpt

Mild micro-hepatic encephalopathy (MHE) is a severe complication of cirrhosis. At present, there are differences in the consistency of detection strategies and treatment directions for MHE. The characteristic changes in intestinal microbiota and serum metabolites in MHE patients and the possible relevant interaction mechanisms would inevitably affect the developmental direction of MHE. Therefore, the changes in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35350446
DOI: 10.1515/biol-2021-0140

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of intestinal microbiota and serum metabolites in patients with mild hepatic encephalopathyPMID 35350446Read ↗

Fecal microbiota and metabolome characteristics in cirrhotic patients accompanied with hepatic encephalopathySemantic proximity Read ↗

Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based PyrosequencingSemantic proximity Read ↗

Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patientsSemantic proximity Read ↗

Multi-omics reveal mechanisms of action of gut microbes and metabolites in infantile cholestatic hepatopathySemantic proximity Read ↗

Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injurySemantic proximity Read ↗

Gut microbiota-derived metabolites as central regulators in metabolic disordersSemantic proximity Read ↗

Pathological expansion of gut microbiome-associated<i>Enterococcus</i>in advanced cirrhosis corresponds with multilevel perturbations of the gut-liver-immune axisSemantic proximity Read ↗

Immune modulation of gut microbiota and its metabolites in chronic hepatitis BSemantic proximity Read ↗

Effects of Saccharomyces boulardii on the characteristics and metabolomics of the gut microbiota in patients with liver cirrhosisSemantic proximity Read ↗

Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progressionSemantic proximity Read ↗

Urine Metabolomics Analysis for Biomarker Discovery and Detection of Jaundice Syndrome in Patients With Liver DiseaseSemantic proximity Read ↗

Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.